A study of non-metastatic gastric cancer patients undergoing radical gastrectomy revealed that postoperative increases in CEA/CA19-9 levels served as superior prognostic indicators compared to preoperative values, with OS inversely correlating with the magnitude of postoperative tumor marker elevation (33). The gene discussed is CEACAM5; the disease is neoplasm.